Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.
| Alpha-GPC | Phenibut | |
|---|---|---|
| Category | Nootropics | Nootropics |
| Standard Dose | 300-600 mg/day | 250-750 mg as needed, maximum 1-2 times per week (for educational context — carries significant dependence risk) |
| Timing | Morning or pre-workout. Can be taken with or without food. Split into 1-2 doses. | On an empty stomach (food significantly reduces absorption). Onset 2-4 hours. Effects last 4-8 hours with residual effects up to 24 hours. Half-life approximately 5.3 hours. |
| Cycle Duration | Ongoing; no cycling required for standard doses | STRICTLY intermittent use only — maximum 1-2 times per week. NEVER use daily for more than 1 week. Tolerance develops within days, leading to dose escalation and dependence. |
| Evidence Level | strong_human | moderate_human |
Highly bioavailable choline source that crosses the blood-brain barrier efficiently via passive diffusion. Serves as a direct precursor for acetylcholine synthesis and phosphatidylcholine, a major structural component of neuronal membranes. Also stimulates growth hormone release via cholinergic activation of GHRH-releasing neurons in the hypothalamus. Contains ~40% choline by weight.
300-600 mg/day
Morning or pre-workout. Can be taken with or without food. Split into 1-2 doses.
Ongoing; no cycling required for standard doses
Beta-phenyl derivative of GABA that crosses the blood-brain barrier (unlike GABA itself) due to the addition of a phenyl ring. Acts as a full agonist at GABA-B receptors with 30-68x lower affinity than baclofen, requiring correspondingly higher doses. Also binds to and blocks alpha-2-delta subunit-containing voltage-dependent calcium channels (VDCCs), making it a gabapentinoid similar to gabapentin and pregabalin. At low concentrations, mildly increases dopamine levels in the brain, providing stimulatory and nootropic effects alongside anxiolysis. Weak agonist activity at GABA-A receptors at higher doses.
250-750 mg as needed, maximum 1-2 times per week (for educational context — carries significant dependence risk)
On an empty stomach (food significantly reduces absorption). Onset 2-4 hours. Effects last 4-8 hours with residual effects up to 24 hours. Half-life approximately 5.3 hours.
STRICTLY intermittent use only — maximum 1-2 times per week. NEVER use daily for more than 1 week. Tolerance develops within days, leading to dose escalation and dependence.
Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.
Get Your Free Protocol →or take the assessment →